IM Cannabis Announces Closing of the Sale of IMC Holdings and Its European-Focused Operations, Strengthens Balance Sheet
PR Newswire•29/09/2026•07:07 ET
0
Key Highlights
- ➤Transaction closing sells IMC Holdings and European-focused operations to Slil.
- ➤C$3 million expected improvement in shareholders' equity, based on unaudited pro forma analysis.
- ➤C$3 million advance payment comprised transaction consideration.
- ➤Retained liabilities capped at C$9.4 million, excluding Target Subsidiaries' direct liabilities.
- ➤IM Cannabis (IMCC) will focus resources on retained Israeli medical cannabis operations.
Expert Statements
Oren Shuster, CEO and director of IM Cannabis Corp.
“The Company intends to focus its resources on its retained Israeli medical cannabis operations while continuing to evaluate additional opportunities.”
IM Cannabis Announces Closing of the Sale of IMC Holdings and Its European-Focused Operations, Strengthens Balance Sheet PR Newswire
Transaction Expected to Result in an Improvement of Approximately C$3 Million in Shareholders' Equity
Get started
Create a free account to read the full story.